- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06076889
Power Over Pain Portal: A Stepped-care Virtual Solution to Deliver Early Intervention to Canadian Youth With Chronic Pain
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Chitra Lalloo, PhD
- Phone Number: 302332 416-813-7654
- Email: chitra.lalloo@sickkids.ca
Study Contact Backup
- Name: Jennifer N Stinson, RN, PhD
- Phone Number: 304514 416-813-7654
- Email: jennifer.stinson@sickkids.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Recruiting
- The Hospital for Sick Children
-
Principal Investigator:
- Jennifer Stinson, RN, PhD
-
Contact:
- Rachel Kelly, BA
- Phone Number: 302314 416-813-7654
- Email: rachelr.kelly@sickkids.ca
-
Contact:
- Chitra Lalloo, BHSc, PhD
- Phone Number: 302332 416-813-7654
- Email: chitra.lalloo@sickkids.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants will be recruited from a community-based sample of 100 youth with chronic pain using respondent-driven sampling (RDS), a network-based (i.e. snowball-type) method wherein a diverse group of youth with chronic pain ("seeds") provide study information to members of their social networks
As per RDS recommendations, the "seeds" will be sociodemographically diverse, live in a variety of geographical areas, and be "high energy sociometric stars" who are committed to the study goals (i.e., our diverse youth advisory group). this strategy will seek to maximize variability in age, sex, gender, ethnicity, SES and rurality.
This study focuses on youth marginalized by membership in racialized groups, SES as defined by neighbourhood, rural/urban status, sex and gender, and sexual orientation. Those belonging to a racialized group, living in a low SES neighbourhood, and/or rural location will be considered marginalized.
Description
Inclusion Criteria:
- Experience chronic pain
- Speak and read English
- Access to Internet / Smartphone (or will be loaned study phone with data plan)
- Intend to use the portal for 2 months
Exclusion Criteria:
- Youth self-reports:
- Receiving tertiary care or are on waitlists for tertiary care paediatric chronic pain programs
- Have moderate to severe cognitive impairment that may impact their ability to understand and use the Power over Pain Portal or complete self-reported outcomes
- Have untreated major psychiatric illness (e.g., anorexia, psychosis) and/or active suicidality at the time of screening
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability
Time Frame: 8 weeks
|
This will be assessed using the Acceptability e-Scale administered at T2 and assessed during the post-implementation qualitative interview.
The minimum value is 1 and the maximum value is 5. Higher scores on the Acceptability e-Scale indicate a better outcome.
|
8 weeks
|
Adoption (i.e.,rate of uptake of the Power over Pain Portal)
Time Frame: 8 weeks
|
Characterized via the user-level analytics of interactions with each feature.
The benchmark will be 75% of users completing 3/4 portal assessment and accessing ≥ portal intervention.
|
8 weeks
|
Appropriateness (i.e., perceived fit and compatibility of the Power over Pain Portal to the needs of users)
Time Frame: 8 weeks
|
Assessed via the post-implementation qualitative interview.
|
8 weeks
|
Portal Feasibility as assessed by the extent to which the Power over Pain Portal can be used as planned
Time Frame: 8 weeks
|
Assessed using frequency counts and percentages of types/severity of problems encountered via monthly audit of technical support tickets
|
8 weeks
|
Portal Feasibility as assessed by the extent to which the Power over Pain Portal can be used as planned
Time Frame: 8 weeks
|
Assessed via characterization of the severity of encountered issues on the Power over Pain portal
|
8 weeks
|
Fidelity
Time Frame: 8 weeks
|
Characterized by intervention use analytics.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Client outcomes
Time Frame: 8 weeks
|
Pain intensity as assessed by the 1-item PROMIS pediatric numeric rating scale v1.0 - Pain Intensity.
This maximum score on the scale is 10 and the minimum score is 0, with higher scores indicating higher levels of pain experienced by the participant.
This will be administered at T1 and T2
|
8 weeks
|
Client outcomes
Time Frame: 8 weeks
|
Pain interference as assessed by the the PROMIS pediatric short form v2.0 - Pain Interference 8a.
The maximum score on the scale is 5 and the lowest score is 1, with higher scores indicating higher pain interference in the participant's life.
This will be administered at T1 and T2.
|
8 weeks
|
Client outcomes
Time Frame: 8 weeks
|
Anxiety as assessed by the the PROMIS pediatric short form v2.0 - Anxiety 8a.
The maximum score on the scale is 5 and the lowest score is 1, with higher scores indicating higher levels of anxiety in the participant's life.
This will be administered at T1 and T2.
|
8 weeks
|
Client outcomes
Time Frame: 8 weeks
|
Depressive symptoms as assessed by the the PROMIS pediatric short form v2.0 - Depressive Symptoms 8a.
The maximum score on the scale is 5 and the lowest score is 1, with higher scores indicating higher levels of depression in the participant's life.
This will be administered at T1 and T2.
|
8 weeks
|
Client outcomes
Time Frame: 8 weeks
|
Insomnia as assessed by the the 7-item Insomnia Severity Index.
The maximum score on the scale is 4 and the lowest score is 0, with higher scores indicating more severe levels of insomnia experienced by the patient.
This will be administered at T1 and T2.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB#
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Vastra Gotaland RegionActive, not recruitingPain, Chronic | Widespread Chronic PainSweden
-
Washington University School of MedicineCompletedHip Pain Chronic | Back Pain | Chronic Pain | Knee Pain ChronicUnited States
Clinical Trials on Power over Pain Portal
-
The Hospital for Sick ChildrenUniversity Health Network, Toronto; University of British Columbia; Centre for... and other collaboratorsRecruiting
-
Oregon Health and Science UniversityCompleted
-
Gazi UniversityCompletedTrigger Point Pain, MyofascialTurkey
-
Cairo UniversityNot yet recruiting
-
Mashhad University of Medical SciencesUnknownMyofacial Pain SyndromeIran, Islamic Republic of
-
University of Colorado, DenverCompletedOtitis MediaUnited States
-
Cairo UniversityNot yet recruiting
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHealthy | Sleep DisorderUnited States
-
Ohio State UniversityRecruitingSleep DeprivationUnited States